About Par Pacific Holdings Inc. Par Pacific Holdings, Inc. engages in the operation of energy and infrastructure businesses. It operates through the following segments: Refining, Retail, Logistics, ...
GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...
CNH has announced two senior leadership appointments effective January 1, 2026, naming Carlo Materazzo as Chief Manufacturing Officer and Britton Worthen as Chief Legal and Compliance Officer.
All earnings call transcripts on PAR Technology Corporation (PAR) stock. Read or listen to the conference call. Download the investor presentation - earnings call slides.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback